Schedule 13D ownership disclosure

Nabriva Therapeutics AG

Security class unavailable · CUSIP: 62957M104

Event date: 2015-09-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
14.5200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-15-000713
Form type
SC 13D
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Oct 02, 2015
Reporting period
Sep 23, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub